Treatment of Cholesterol-Fed Rabbits with Dietary Vitamins E and C Inhibits Lipoprotein Oxidation but Not Development of Atherosclerosis
- 1 November 1994
- journal article
- research article
- Published by Elsevier in Journal of Nutrition
- Vol. 124 (11) , 2123-2130
- https://doi.org/10.1093/jn/124.11.2123
Abstract
New Zealand White rabbits were made hypercholesterolemic by feeding a high cholesterol diet (10 g/kg diet) with or without added antioxidants. The antioxidants used were either probucol (10 g/kg) or vitamin E (10 g/kg) plus vitamin C (0.6 g/kg). Serum cholesterol concentrations were monitored as a function of time. At the end of 10 wk, serum and lipoprotein vitamin E concentrations, the extent of oxidation of lipoprotein fractions (thiobarbituric acid reacting substances), the susceptibility of lipoprotein to oxidation in vitro (conjugated diene formation) and the extent of atherosclerosis (aortic area stained by Sudan IV and plaque thickness) were measured. Rabbits fed diets supplemented with vitamins E and C had markedly higher serum vitamin E concentrations, marked vitamin E enrichment in all lipoprotein fractions, less oxidation in VLDL and LDL and enhanced resistance of LDL to further in vitro oxidation, but did not have significantly less aortic atherosclerosis. Rabbits given supplemental probucol likewise exhibited reduced oxidation of lipoproteins. However, aortic atherosclerosis in these animals was significantly lower, as were serum cholesterol concentrations. Inhibition of lipoprotein oxidation itself was not sufficient to reduce atherosclerosis in cholesterol-fed New Zealand White rabbits.Keywords
This publication has 25 references indexed in Scilit:
- Vitamin E Consumption and the Risk of Coronary Disease in WomenNew England Journal of Medicine, 1993
- Etoposide treatment suppresses atherosclerotic plaque development in cholesterol-fed rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbitsAtherosclerosis, 1991
- Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosisFree Radical Biology & Medicine, 1991
- The antioxidant butylated hydroxytoluene protects against atherosclerosis.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Antioxidant activity of probucol and its analogs in hypercholesterolemic Watanabe rabbitsJournal of Medicinal Chemistry, 1991
- Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levelsAtherosclerosis, 1989